A number of blood-based protein biomarkers have been used for human cancer screening and monitoring using immunohistochemical methods, including: CEA for colorectal cancer, PSA for prostate cancer, CA-125 for ovarian cancer, and alpha-fetoprotein (AFP) for hepatocellular carcinoma (140–143). Here, AFP is linked to prostate carcinoma.